Testing EPI-001 for male and female pattern hair loss
Part of Skin clinical trials.
This study tests an experimental treatment called EPI-001 for androgenetic alopecia—the most common type of hair loss affecting men and women. Researchers will measure how well it works by tracking hair growth over time using special photography and scalp analysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older
- You have been diagnosed with androgenetic alopecia (pattern hair loss)
- You agree not to change your hairstyle, hair length, or hair color during the study
- You avoid other hair-growth products and procedures (like minoxidil or PRP) during the study
- You accept scalp tattooing marks and hair trimming for measurement photography
- You have not had a hair transplant, stem cell therapy, or gene therapy before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental medication (CKD-843) for men with male pattern baldness. It aims to see if the treatment is safe and effective for regrowing hair.
This trial tests a new topical solution containing dutasteride to treat male pattern baldness. It aims to see if applying the medication directly to the scalp can help regrow hair with fewer side effects than pills.
This trial tests a new treatment (DA-001) to reduce hair shedding and help hair grow back in people with telogen effluvium—a temporary hair loss condition. The treatment is applied directly to the scalp, and participants will be followed to see how well it works.
This trial tests a cosmetic anti-hair loss product in men with early to moderate male pattern baldness. It looks at how well the product works and if it can help slow or reduce hair loss.
This study tests two new topical treatments (DA-002 and DA-005) for hair loss in people with pattern baldness. The goal is to see if they can help hair grow back.
This Phase 3 study tests whether a specific hair lotion works and is safe for men with male pattern hair loss. It also checks that results are consistent while you keep similar hair care and avoid certain other hair-loss treatments.
Hear when a new Androgenetic Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.